Translating Pre-Clinical Doses into Efficacious Human Dosages in the Clinic & Reviewing Recent Dosing Guidance
Time: 11:45 am
day: Conference Day One
Details:
- Clarifying regulatory expectations for translating pre-clinical doses into efficacious human dosages
- Investigating immunogenicity and the impact it has on dosing
- Reflecting on recent FDA guidance from Project Optimus and its impact on oncology dosing
